JANE STREET GROUP, LLC - THERAVANCE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 5 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2022$1,184,832
+330.8%
105,600
+247.4%
0.00%–
Q2 2022$275,000–30,400–0.00%–
 Download
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 2,300$33,0000.00%
JPMORGAN CHASE & CO 30,300$440,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders